These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

938 related items for PubMed ID: 23948462

  • 1. The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis.
    Teo M, Karakaya E, Young CA, Dyker KE, Coyle C, Sen M, Prestwich RJ.
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):647-53. PubMed ID: 23948462
    [Abstract] [Full Text] [Related]

  • 2. Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by surgery and concurrent chemoradiotherapy improves outcome of recurrent advanced head and neck squamous cell carcinoma.
    Yang WC, Chen CH, Tang JY, Wu CF, Liu YC, Sun Y, Lin SF.
    Anticancer Res; 2014 Jul; 34(7):3765-73. PubMed ID: 24982400
    [Abstract] [Full Text] [Related]

  • 3. Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status.
    Lowe NM, Bernstein JM, Mais K, Garcez K, Lee LW, Sykes A, Thomson DJ, Homer JJ, West CM, Slevin NJ.
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):389-401. PubMed ID: 29222650
    [Abstract] [Full Text] [Related]

  • 4. Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer.
    Wang HM, Lin CY, Hsieh CH, Hsu CL, Fan KH, Chang JT, Huang SF, Kang CJ, Liao CT, Ng SH, Yen TC.
    J Formos Med Assoc; 2017 Mar; 116(3):185-192. PubMed ID: 27133181
    [Abstract] [Full Text] [Related]

  • 5. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.
    Prestwich RJ, Öksüz DÇ, Dyker K, Coyle C, Şen M.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e237-43. PubMed ID: 21620580
    [Abstract] [Full Text] [Related]

  • 6. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
    Budach W, Bölke E, Kammers K, Gerber PA, Orth K, Gripp S, Matuschek C.
    Radiother Oncol; 2016 Feb 15; 118(2):238-43. PubMed ID: 26589131
    [Abstract] [Full Text] [Related]

  • 7. Concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck.
    Komatsu M, Shiono O, Taguchi T, Sakuma Y, Nishimura G, Sano D, Sakuma N, Yabuki K, Arai Y, Takahashi M, Isitoya J, Oridate N.
    Jpn J Clin Oncol; 2014 May 15; 44(5):416-21. PubMed ID: 24688084
    [Abstract] [Full Text] [Related]

  • 8. Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck.
    Katori H, Tsukuda M.
    Clin Oncol (R Coll Radiol); 2005 May 15; 17(3):148-52. PubMed ID: 15900997
    [Abstract] [Full Text] [Related]

  • 9. The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.
    Kim R, Hahn S, Shin J, Ock CY, Kim M, Keam B, Kim TM, Kim DW, Heo DS.
    Cancer Res Treat; 2016 Jul 15; 48(3):907-16. PubMed ID: 26582394
    [Abstract] [Full Text] [Related]

  • 10. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial.
    Lorch JH, Goloubeva O, Haddad RI, Cullen K, Sarlis N, Tishler R, Tan M, Fasciano J, Sammartino DE, Posner MR, TAX 324 Study Group.
    Lancet Oncol; 2011 Feb 15; 12(2):153-9. PubMed ID: 21233014
    [Abstract] [Full Text] [Related]

  • 11. A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.
    Hitt R, Grau JJ, López-Pousa A, Berrocal A, García-Girón C, Irigoyen A, Sastre J, Martínez-Trufero J, Brandariz Castelo JA, Verger E, Cruz-Hernández JJ, Spanish Head and Neck Cancer Cooperative Group (TTCC).
    Ann Oncol; 2014 Jan 15; 25(1):216-25. PubMed ID: 24256848
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastases.
    Izawa N, Onozawa Y, Hikosaka T, Hamauchi S, Tsushima T, Todaka A, Machida N, Haraguchi Y, Ogawa H, Nishimura T, Nakagawa M, Fuke T, Iida Y, Kamijo T, Onitsuka T, Boku N, Yasui H, Yokota T.
    Int J Clin Oncol; 2015 Jun 15; 20(3):455-62. PubMed ID: 25248339
    [Abstract] [Full Text] [Related]

  • 13. Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study.
    Takácsi-Nagy Z, Hitre E, Remenár É, Oberna F, Polgár C, Major T, Gödény M, Fodor J, Kásler M.
    Strahlenther Onkol; 2015 Aug 15; 191(8):635-41. PubMed ID: 25782685
    [Abstract] [Full Text] [Related]

  • 14. A prospective phase II randomized study of docetaxel combined with lobaplatin versus TPF regimen induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma.
    Zhang M, Chen Y, Wu W, Jin F, Li Y, Long J, Luo X, Gong X, Chen X, Liu L, Tang H, Wang Z.
    J Cancer Res Clin Oncol; 2023 Dec 15; 149(20):18081-18091. PubMed ID: 37985501
    [Abstract] [Full Text] [Related]

  • 15. Phase II study of docetaxel, cisplatin, and concurrent radiation followed by platinum-based adjuvant chemotherapy for technically unresectable, locally advanced head and neck squamous cell carcinoma.
    Nakahara S, Takenaka Y, Ogawa K, Nishiike S, Yamamoto Y, Seo Y, Isohashi F, Suzuki O, Yoshioka Y, Sumida I, Yoshii T, Tomiyama Y, Inohara H.
    Int J Clin Oncol; 2016 Dec 15; 21(6):1030-1037. PubMed ID: 27306220
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.
    Cho H, Nishiike S, Yamamoto Y, Takenaka Y, Nakahara S, Yasui T, Hanamoto A, Inohara H.
    Auris Nasus Larynx; 2015 Oct 15; 42(5):396-400. PubMed ID: 25721854
    [Abstract] [Full Text] [Related]

  • 18. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.
    Karakaya E, Yetmen O, Oksuz DC, Dyker KE, Coyle C, Sen M, Prestwich RJ.
    Oral Oncol; 2013 Jan 15; 49(1):55-9. PubMed ID: 22858313
    [Abstract] [Full Text] [Related]

  • 19. Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer.
    Herman LC, Chen L, Garnett A, Feldman LE, Smith B, Weichselbaum RR, Spiotto MT.
    Oral Oncol; 2014 Jan 15; 50(1):52-8. PubMed ID: 24055193
    [Abstract] [Full Text] [Related]

  • 20. Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma.
    Nishimura G, Taguchi T, Takahashi M, Shiono O, Komatsu M, Sano D, Yabuki K, Arai Y, Takahashi H, Hata M, Oridate N.
    Cancer Chemother Pharmacol; 2016 Jun 15; 77(6):1315-9. PubMed ID: 27154176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.